💡 Harvard Pilgrim Health Care Institute's Marie-France Hivert is the lead author on the first paper in this series on #gestationaldiabetes, online now in The Lancet. Dr. Hivert and team posit that, contrary to view that gestational diabetes begins late in pregnancy, scientific and clinical evidence suggests it actually has pathophysiological foundations before pregnancy. Therefore, gestational diabetes can be present early in pregnancy, with long-reaching effects beyond. Learn more, and delve into the series, here ⬇ ⬇ ⬇
Gestational diabetes affects 1 in 7 pregnancies and is the most common medical pregnancy complication worldwide. Cases of gestational diabetes are increasing and becoming more complex due to higher levels of risk factors, such as obesity. Without treatment, gestational diabetes can lead to increased risk of: - High blood pressure - Caesarean sections - Mental health conditions - Health complications later in life, such as type 2 diabetes and cardiovascular disease - Complications for the baby at delivery Testing and treatment for the condition often occurs late into the second or third trimester. Authors of a new Lancet Series call for earlier intervention to prevent complications and improve long-term health outcomes. “Our new Series emphasises the urgent need for a major shift in how [gestational diabetes] is first diagnosed and managed, not only during pregnancy but throughout the lifetime of mothers and their babies,” said Series lead, Prof. David Simmons. Find out more ▶️ https://hubs.li/Q02C0SG30
